查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1423950

解毒剂市场、份额、规模、趋势、行业分析报告：按类型、给药途径、分销管道、最终用途、地区、细分市场预测，2024-2032

Antidote Market Share, Size, Trends, Industry Analysis Report, By Type (Chemical Antidote, Physical Antidote, Pharmacological Antidote), By Route of Administration, By Distribution Channel, By End-use, By Region, And Segment Forecasts, 2024- 2032
出版日期: | 出版商: Polaris Market Research | 英文 116 Pages | 商品交期: 最快1-2个工作天内

价格

根据Polaris Market Research的最新研究，预计到2032年，全球解毒剂市场规模将达到40.5236亿美元。 该报告提供了对当前市场动态的详细见解，并对未来市场成长进行了分析。

市场主要受到蛇咬伤流行及其相关负面影响的推动。 例如，2023 年 PLOS 发表的一篇研究论文报告称，印度约有 58,000 人因蛇咬伤死亡。 此外，药物过量的增加是市场的主要驱动因素。 根据美国卫生与公众服务部的数据，2021 年美国约有 106,699 人因药物过量死亡。 解毒剂透过中和某些药物来发挥作用。 例如，纳洛酮通常用于逆转阿片类药物过量期间的呼吸抑制。 解毒剂的这些特点有助于市场的成长。

此外，职业中毒发生率的上升也是解毒剂需求增加的重要原因。 阿片类药物过量、氢氰酸中毒、一氧化碳中毒、铅中毒、有机磷中毒等发生率的增加扩大了解毒剂的使用。 例如，根据 NCBI 2020 年 12 月的研究论文，全球约有 3.85 亿起农药意外中毒病例，导致 11,000 人死亡。 因此，预计市场在预测期内将快速成长。

此外，一系列旨在教育大众进行毒素识别的意识举措，加上政府努力提高解毒剂和药物知识，预计将推动整体市场成长。 另一方面，正在进行的研究和开发的重点是提高有毒物质在中毒和接触有毒物质管理中的可用性、有效性和安全性，并将在不久的将来将其推向市场。这似乎提供了有利可图的机会机会。

然而，由于製造限制和监管障碍，解毒剂的供应有限，可能会阻碍获得救生解毒剂。 某些解毒剂的高成本可能是一个经济障碍。 此外，储存条件、保质期、知识和训练需求可能会限制解毒剂的应用。

解毒剂市场报告要点

化学解毒剂所占比重最大。

由于住院病患数量、重症监护设施和训练有素的医疗专业人员数量不断增加，医院主导市场

由于鸦片类药物危机、成瘾病例不断增加以及参与研发的大公司的存在，北美占据了最大的份额。

主要市场参与者包括辉瑞、Hikma Pharmaceuticals、Mylan、Fresenius、Zydus Lifesciences、Endo International、Baxter 和 Emergent Biosolutions。

目录

简介

  • 报告说明
    • 研究目的
    • 市场范围
    • 假设
  • 利害关係人

第 2 章执行摘要

第3章研究方法

第4章全球解毒□□剂市场洞察

  • 解药市场－通路概况
  • 解毒剂市场动态
    • 推动者和机会
      • 中毒发生率增加
      • 药物滥用现像日益严重
    • 抑制因素和挑战
      • 成本高
  • PESTEL 分析
  • 解毒剂市场通路趋势
  • 价值链分析
  • COVID-19 感染的影响分析

第 5 章全球解毒□□剂市场：依给药途径

  • 主要发现
  • 简介
  • 口头
  • 本地
  • 注射
  • 其他

第 6 章全球解毒□□剂市场：按类型

  • 主要发现
  • 简介
  • 化学解毒剂
  • 物理解毒剂
  • 药物理解毒剂

第7章全球解毒□□剂市场：依通路划分

  • 主要发现
  • 简介
  • 医院药房
  • 零售药局
  • 网路药局

第 8 章全球解毒□□剂市场：按地区

  • 主要发现
  • 简介
    • 2019-2032 年按地区划分的解毒剂市场评估
  • 解毒剂市场－北美
    • 北美：解毒剂市场，依给药途径，2019-2032 年
    • 北美：解毒剂市场，依通路划分，2019-2032 年
    • 北美：解毒剂市场，按类型，2019-2032 年
    • 解毒剂市场－美国
    • 解毒剂市场 - 加拿大
  • 解毒剂市场 - 欧洲
    • 欧洲：解毒剂市场（依给药途径），2019-2032 年
    • 欧洲：解毒剂市场，依通路划分，2019-2032 年
    • 欧洲：解毒剂市场，依类型，2019-2032 年
    • 解毒剂市场 - 英国
    • 解毒剂市场－法国
    • 解毒剂市场－德国
    • 解毒剂市场 - 义大利
    • 解毒剂市场 - 西班牙
    • 解毒剂市场 - 荷兰
    • 解毒剂市场 - 俄罗斯
  • 解毒剂市场 - 亚太地区
    • 亚太地区：解毒剂市场（依给药途径），2019-2032 年
    • 亚太地区：解毒剂市场，依通路划分，2019-2032 年
    • 亚太地区：2019-2032 年解毒剂市场（按类型）
    • 解毒剂市场 - 中国
    • 解毒剂市场 - 印度
    • 解毒剂市场 - 马来西亚
    • 解毒剂市场 - 日本
    • 解毒剂市场 - 印度尼西亚
    • 解毒剂市场 - 韩国
  • 解毒剂市场 - 中东和非洲
    • 中东和非洲：解毒剂市场（按给药途径），2019-2032 年
    • 中东与非洲：解毒剂市场，依通路划分，2019-2032 年
    • 中东和非洲：解毒剂市场，按类型，2019-2032 年
    • 解毒剂市场－沙乌地阿拉伯
    • 解毒剂市场－阿拉伯联合大公国
    • 解毒剂市场 - 以色列
    • 解毒剂市场 - 南非
  • 解毒剂市场 - 拉丁美洲
    • 拉丁美洲：解毒剂市场，依给药途径划分，2019-2032 年
    • 拉丁美洲：解毒剂市场，依通路划分，2019-2032 年
    • 拉丁美洲：解毒剂市场，按类型，2019-2032 年
    • 解毒剂市场 - 墨西哥
    • 解毒剂市场 - 巴西
    • 解毒剂市场 - 阿根廷

第9章竞争态势

  • 扩张与收购分析
    • 放大
    • 收购
  • 伙伴关係/协作/协议/揭露

第10章公司简介

  • Pfizer Inc.
  • Hikma Pharmaceuticals PLC
  • Dr. Reddy's Laboratories Ltd
  • Mylan N.V.
  • Fresenius Kabi AG
  • Zydus Lifesciences Ltd.
  • Endo International plc
  • Novartis AG
  • Baxter International, Inc.
  • Emergent BioSolutions Inc
Product Code: PM4182

The global antidote market size is expected to reach USD 4,052.36 Million by 2032, according to a new study by Polaris Market Research. The report "Antidote Market Share, Size, Trends, Industry Analysis Report, By Type (Chemical Antidote, Physical Antidote, Pharmacological Antidote), By Route of Administration, By Distribution Channel, By End-use, By Region, And Segment Forecasts, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The market is predominantly propelled by the prevalence of snakebites and the associated adverse effects. For instance, a research article published in PLOS in 2023 reported approximately 58,000 deaths in India attributed to snake bites. Additionally, the increase in the number of drug overdoses is a key driver for the market. According to the U.S. Department of Health & Human Services, around 106,699 drug overdose deaths were recorded in the U.S. in 2021. Antidotes work to neutralize specific drugs. For instance, Naloxone is commonly used to reverse respiratory depression in opioid overdoses. These capabilities of antidotes contribute to the growth of the market.

Moreover, the escalating prevalence of occupational poisoning is playing a significant role in the heightened demand for antidotes. The applications of antidotes are expanding due to the increasing incidence of conditions such as opioid overdose, cyanide and CO poisoning, lead poisoning, and organo-phosphate poisoning, among others. For instance, according to a research article by NCBI in December 2020, there were approximately 385 million instances of unintentional pesticide poisoning worldwide, resulting in 11,000 deaths. Consequently, the market is anticipated to experience rapid growth during the forecast period.

Moreover, a series of awareness initiatives aimed at educating the public on toxin identification, coupled with government efforts to enhance knowledge of antidotes and drugs, is expected to propel the overall market growth. On the flip side, ongoing research and development endeavors are focused on improving availability, effectiveness, and safety in managing poisonings and toxic exposures, presenting lucrative opportunities for the market soon.

However, the limited availability of antidotes due to the manufacturing constraints and regulatory hurdles may impede access to the life-saving antidotes. The high costs associated with certain antidotes could create financial barriers. Additionally, storage requirements, shelf-life, and the need for knowledge and training may constrain the applications of antidotes.

Antidote Market Report Highlights

Chemical antidote held the largest share, due to minimized compilations, consistent outcomes, and precise dosing

Hospitals dominated the market, owing to increasing number of hospitalizations, batter facilities, and trained medical professionals

North America accounted for the largest share, due to rise in opioid crisis, poisoning cases, and presence of key companies involved in R&D

The key market players include Pfizer, Hikma Pharmaceuticals, Mylan, Fresenius, Zydus Lifesciences, Endo International, Baxter, & Emergent BioSolutions.

Polaris Market Research has segmented the antidote market report based on type, route of administration, distribution channel, end use, and region:

Antidote, Type Outlook (Revenue - USD Million, 2023 - 2032)

  • Chemical Antidote
  • Physical Antidote
  • Pharmacological Antidote

Antidote, Route of Administration Outlook (Revenue - USD Million, 2023 - 2032)

  • Oral
  • Topical
  • Injectable
  • Others

Antidote, Distribution Channel Outlook (Revenue - USD Million, 2023 - 2032)

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Antidote, End Use Outlook (Revenue - USD Million, 2023 - 2032)

  • Hospital
  • Homecare
  • Specialty Clinics
  • Others

Antidote, Regional Outlook (Revenue - USD Million, 2023 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Antidote Market Insights

  • 4.1. Antidote Market - Distribution Channel Snapshot
  • 4.2. Antidote Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Incidence of Poisonings
      • 4.2.1.2. Growing Drug Abuse
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Costs
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Antidote Market Distribution Channel Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Antidote Market, by Route of Administration

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • 5.3. Oral
    • 5.3.1. Global Antidote Market, by Oral, by Region, 2019-2032 (USD Million)
  • 5.4. Topical
    • 5.4.1. Global Antidote Market, by Topical, by Region, 2019-2032 (USD Million)
  • 5.5. Injectable
    • 5.5.1. Global Antidote Market, by Injectable, by Region, 2019-2032 (USD Million)
  • 5.6. Others
    • 5.6.1. Global Antidote Market, by Others, by Region, 2019-2032 (USD Million)

6. Global Antidote Market, by Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Antidote Market, by Type, 2019-2032 (USD Million)
  • 6.3. Chemical Antidote
    • 6.3.1. Global Antidote Market, by Chemical Antidote, by Region, 2019-2032 (USD Million)
  • 6.4. Physical Antidote
    • 6.4.1. Global Antidote Market, by Physical Antidote, by Region, 2019-2032 (USD Million)
  • 6.5. Pharmacological Antidote
    • 6.5.1. Global Antidote Market, by Pharmacological Antidote, by Region, 2019-2032 (USD Million)

7. Global Antidote Market, by Distribution Channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • 7.3. Hospital Pharmacies
    • 7.3.1. Global Antidote Market, by Hospital Pharmacies, By Region, 2019-2032 (USD Million)
  • 7.4. Retail Pharmacies
    • 7.4.1. Global Antidote Market, by Retail Pharmacies, By Region, 2019-2032 (USD Million)
  • 7.5. Online Pharmacies
    • 7.5.1. Global Antidote Market, by Online Pharmacies, By Region, 2019-2032 (USD Million)

8. Global Antidote Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Antidote Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Antidote Market - North America
    • 8.3.1. North America: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
    • 8.3.2. North America: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.3.3. North America: Antidote Market, by Type, 2019-2032 (USD Million)
    • 8.3.4. Antidote Market - U.S.
      • 8.3.4.1. U.S.: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Antidote Market, by Type, 2019-2032 (USD Million)
    • 8.3.5. Antidote Market - Canada
      • 8.3.5.1. Canada: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Antidote Market, by Type, 2019-2032 (USD Million)
  • 8.4. Antidote Market - Europe
    • 8.4.1. Europe: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.4.3. Europe: Antidote Market, by Type, 2019-2032 (USD Million)
    • 8.4.4. Antidote Market - UK
      • 8.4.4.1. UK: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Antidote Market, by Type, 2019-2032 (USD Million)
    • 8.4.5. Antidote Market - France
      • 8.4.5.1. France: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.5.3. France: Antidote Market, by Type, 2019-2032 (USD Million)
    • 8.4.6. Antidote Market - Germany
      • 8.4.6.1. Germany: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Antidote Market, by Type, 2019-2032 (USD Million)
    • 8.4.7. Antidote Market - Italy
      • 8.4.7.1. Italy: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Antidote Market, by Type, 2019-2032 (USD Million)
    • 8.4.8. Antidote Market - Spain
      • 8.4.8.1. Spain: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Antidote Market, by Type, 2019-2032 (USD Million)
    • 8.4.9. Antidote Market - Netherlands
      • 8.4.9.1. Netherlands: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Antidote Market, by Type, 2019-2032 (USD Million)
    • 8.4.10. Antidote Market - Russia
      • 8.4.10.1. Russia: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Antidote Market, by Type, 2019-2032 (USD Million)
  • 8.5. Antidote Market - Asia Pacific
    • 8.5.1. Asia Pacific: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Antidote Market, by Type, 2019-2032 (USD Million)
    • 8.5.4. Antidote Market - China
      • 8.5.4.1. China: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.4.3. China: Antidote Market, by Type, 2019-2032 (USD Million)
    • 8.5.5. Antidote Market - India
      • 8.5.5.1. India: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.5.3. India: Antidote Market, by Type, 2019-2032 (USD Million)
    • 8.5.6. Antidote Market - Malaysia
      • 8.5.6.1. Malaysia: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Antidote Market, by Type, 2019-2032 (USD Million)
    • 8.5.7. Antidote Market - Japan
      • 8.5.7.1. Japan: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Antidote Market, by Type, 2019-2032 (USD Million)
    • 8.5.8. Antidote Market - Indonesia
      • 8.5.8.1. Indonesia: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Antidote Market, by Type, 2019-2032 (USD Million)
    • 8.5.9. Antidote Market - South Korea
      • 8.5.9.1. South Korea: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Antidote Market, by Type, 2019-2032 (USD Million)
  • 8.6. Antidote Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Antidote Market, by Type, 2019-2032 (USD Million)
    • 8.6.4. Antidote Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Antidote Market, by Type, 2019-2032 (USD Million)
    • 8.6.5. Antidote Market - UAE
      • 8.6.5.1. UAE: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Antidote Market, by Type, 2019-2032 (USD Million)
    • 8.6.6. Antidote Market - Israel
      • 8.6.6.1. Israel: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Antidote Market, by Type, 2019-2032 (USD Million)
    • 8.6.7. Antidote Market - South Africa
      • 8.6.7.1. South Africa: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Antidote Market, by Type, 2019-2032 (USD Million)
  • 8.7. Antidote Market - Latin America
    • 8.7.1. Latin America: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Antidote Market, by Type, 2019-2032 (USD Million)
    • 8.7.4. Antidote Market - Mexico
      • 8.7.4.1. Mexico: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Antidote Market, by Type, 2019-2032 (USD Million)
    • 8.7.5. Antidote Market - Brazil
      • 8.7.5.1. Brazil: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Antidote Market, by Type, 2019-2032 (USD Million)
    • 8.7.6. Antidote Market - Argentina
      • 8.7.6.1. Argentina: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Antidote Market, by Type, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Pfizer Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Hikma Pharmaceuticals PLC
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Dr. Reddy's Laboratories Ltd
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Mylan N.V.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Fresenius Kabi AG
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Zydus Lifesciences Ltd.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Endo International plc
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Novartis AG
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Baxter International, Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Emergent BioSolutions Inc
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development

List of Tables

  • Table 1 Global Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 2 Global Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 3 Global Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 4 Antidote Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 5 North America: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 6 North America: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 7 North America: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 8 U.S.: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 9 U.S.: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 10 U.S.: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 11 Canada: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 12 Canada: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 13 Canada: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 14 Europe: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 15 Europe: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 16 Europe: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 17 UK: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 18 UK: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 19 UK: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 20 France: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 21 France: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 22 France: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 23 Germany: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 24 Germany: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 25 Germany: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 26 Italy: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 27 Italy: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 28 Italy: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 29 Spain: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 30 Spain: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 31 Spain: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 32 Netherlands: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 33 Netherlands: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 34 Netherlands: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 35 Russia: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 36 Russia: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 37 Russia: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 38 Asia Pacific: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 39 Asia Pacific: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 41 China: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 42 China: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 43 China: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 44 India: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 45 India: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 46 India: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 47 Malaysia: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 48 Malaysia: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 49 Malaysia: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 50 Japan: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 51 Japan: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 52 Japan: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 53 Indonesia: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 54 Indonesia: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 55 Indonesia: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 56 South Korea: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 57 South Korea: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 58 South Korea: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 59 Middle East & Africa: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 60 Middle East & Africa: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 61 Middle East & Africa: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 62 Saudi Arabia: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 63 Saudi Arabia: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 64 Saudi Arabia: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 65 UAE: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 66 UAE: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 67 UAE: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 68 Israel: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 69 Israel: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 70 Israel: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 71 South Africa: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 72 South Africa: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 73 South Africa: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 74 Latin America: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 75 Latin America: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 76 Latin America: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 77 Mexico: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 78 Mexico: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 79 Mexico: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 80 Brazil: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 81 Brazil: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 82 Brazil: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 83 Argentina: Antidote Market, by Route of Administration, 2019-2032 (USD Million)
  • Table 84 Argentina: Antidote Market, by Type, 2019-2032 (USD Million)
  • Table 85 Argentina: Antidote Market, by Distribution Channel, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Antidote Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Antidote Market, by Type, 2022 & 2032 (USD Million)
  • Figure 8. Market by Route of Administration
  • Figure 9. Global Antidote Market, by Route of Administration, 2022 & 2032 (USD Million)
  • Figure 10. Market by Distribution Channel
  • Figure 11. Global Antidote Market, by Distribution Channel, 2022 & 2032 (USD Million)
  • Figure 12. Antidote Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 13. Strategic Analysis - Antidote Market